263 related articles for article (PubMed ID: 15068378)
1. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
Varecková E; Mucha V; Wharton SA; Kostolanský F
Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
4. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin.
Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E
Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
7. Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A type.
Hifumi E; Fujimoto N; Ishida K; Kawawaki H; Uda T
J Biosci Bioeng; 2010 Jun; 109(6):598-608. PubMed ID: 20471600
[TBL] [Abstract][Full Text] [Related]
8. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2.
Keleta L; Ibricevic A; Bovin NV; Brody SL; Brown EG
J Virol; 2008 Dec; 82(23):11599-608. PubMed ID: 18829764
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to hidden epitope of influenza A haemagglutinin elicited by anti-idiotypic antibodies.
Kostolanský F; Mucha V; Betáková T; Varecková E
Acta Virol; 1994 Aug; 38(4):215-22. PubMed ID: 7533479
[TBL] [Abstract][Full Text] [Related]
10. The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR.
Macosko JC; Kim CH; Shin YK
J Mol Biol; 1997 Apr; 267(5):1139-48. PubMed ID: 9150402
[TBL] [Abstract][Full Text] [Related]
11. Dual mutations in the HA1 peptide of amantadine-resistant influenza viruses at positions 193 and 225.
Inoue Y; Yoneda M; Kitahori Y
Jpn J Infect Dis; 2007 May; 60(2-3):147-8. PubMed ID: 17515655
[No Abstract] [Full Text] [Related]
12. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
Skehel JJ; Wiley DC
Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
[TBL] [Abstract][Full Text] [Related]
13. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
Korte T; Epand RF; Epand RM; Blumenthal R
Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
[TBL] [Abstract][Full Text] [Related]
14. Mapping the intersubunit region of influenza virus hemagglutinin: comparative CD and FTIR spectroscopic studies on multiple antigenic peptides.
Majer Z; Holly S; Tóth GK; Váradi G; Nagy Z; Horváth A; Rajnavölgyi E; Laczkó I; Hollósi M
Arch Biochem Biophys; 1995 Sep; 322(1):112-8. PubMed ID: 7574664
[TBL] [Abstract][Full Text] [Related]
15. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.
Ilyushina N; Rudneva I; Gambaryan A; Bovin N; Kaverin N
Virology; 2004 Nov; 329(1):33-9. PubMed ID: 15476872
[TBL] [Abstract][Full Text] [Related]
17. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
Tamura M; Webster RG; Ennis FA
J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
[TBL] [Abstract][Full Text] [Related]
18. Acylation of the influenza hemagglutinin modulates fusion activity.
Fischer C; Schroth-Diez B; Herrmann A; Garten W; Klenk HD
Virology; 1998 Sep; 248(2):284-94. PubMed ID: 9721237
[TBL] [Abstract][Full Text] [Related]
19. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
[TBL] [Abstract][Full Text] [Related]
20. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.
Cross KJ; Wharton SA; Skehel JJ; Wiley DC; Steinhauer DA
EMBO J; 2001 Aug; 20(16):4432-42. PubMed ID: 11500371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
